Ceftolozane
Cephalosporin Antibacterial — ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: ceftolozane sulfate, CXA-101, FR 264205, FR-264205, FR264205, zerbaxa
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Ceftolozane is an onp drug in the Cephalosporin Antibacterial class catalogued in DrugCentral. It was first approved by the FDA in 2014. Recorded indications include Abdominal abscess, Abscess of liver, Acute pyelonephritis and Bacterial cystitis.
- Approval status: onp (first approved 2014 by the FDA).
- Drug class: Cephalosporin Antibacterial.
- Indications: Abdominal abscess, Abscess of liver, Acute pyelonephritis, Bacterial cystitis and Bacterial peritonitis and others.
- ATC code: J01DI54 (Other cephalosporins and penems).
- Molecular formula: C23H31N12O8S2+; molecular weight 667.71 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (14)
- Abdominal abscess
- Abscess of liver
- Acute pyelonephritis
- Bacterial cystitis
- Bacterial peritonitis
- Bacterial pyelonephritis
- Cholecystitis
- Haemophilus influenzae pneumonia
- Infectious disease of abdomen
- Nosocomial pneumonia
- Sepsis caused by Haemophilus influenzae
- Sepsis caused by Serratia
- Urinary tract infectious disease
- Ventilator-acquired pneumonia
Mechanism & targets
| Established pharmacologic class | Cephalosporin Antibacterial |
|---|
Regulatory approvals (3)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2019-01-08 | PMDA | — | MSD K.K. | |
| 2015-09-18 | EMA | — | MERCK SHARP & DOHME B.V. | |
| 2014-12-19 | FDA | — | CUBIST PHARMS |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01DI54 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › OTHER BETA-LACTAM ANTIBACTERIALS › Other cephalosporins and penems |
Chemical structure
| Molecular formula | C23H31N12O8S2+ |
|---|---|
| Molecular weight | 667.71 g/mol |
| CAS number | — |
| InChIKey | JHFNIHVVXRKLEF-DCZLAGFPSA-O |
| PubChem CID | 53234134 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Ceftolozane used for?
DrugCentral lists the following indications for Ceftolozane: Abdominal abscess, Abscess of liver, Acute pyelonephritis, Bacterial cystitis, Bacterial peritonitis, Bacterial pyelonephritis, Cholecystitis and Haemophilus influenzae pneumonia and others.
When was Ceftolozane first approved?
Ceftolozane was first approved by the FDA in 2014.
What drug class does Ceftolozane belong to?
Ceftolozane is in the Cephalosporin Antibacterial class.
What is the chemical formula of Ceftolozane?
Ceftolozane has the molecular formula C23H31N12O8S2+ and a molecular weight of 667.71 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4922 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1213250 — compound record and bioactivity
- PubChem CID 53234134 — chemical identifiers
- DrugBank DB09050 — drug record
- FDA UNII 37A4IES95Q — substance identity
- DailyMed: FDA labels for Ceftolozane — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.